L. Giacobazzi

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients

M. Milella, M. Cassatella, S. Ugel, 2023, Oncoimmunology.

B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression

M. Scupoli, S. Ugel, I. Dando, 2024, Scientific reports.

GateMeClass: Gate Mining and Classification of cytometry data

S. Ugel, S. Caligola, A. Adamo, 2024, Bioinformatics.